V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 320004162 | 320005151 | null | -1 | Palliative (P) | 2014-01-08 | 2014-01-08 | CVP R | 01 | N | 320021396 | TRIAL |
| 320004163 | 320005151 | 1.6 | 86.7 | Neo-adjuvant (N) | 2015-12-13 | 2015-12-16 | ICON8 TRIAL | 2 | N | 320021396 | EC |
| 320004164 | 320005151 | 1.7 | 57.8 | Disease modification (D) | 2017-02-16 | 2017-02-25 | Docetaxel 75mg/m2 (21 day) | N | N | 320021396 | CETUXIMAB + CISPLATIN + FU |
| 320004165 | 320002564 | 1.65 | 45 | Adjuvant (A) | 2018-03-18 | 2018-03-18 | Bevacizumab+Carbo+Pacliaxel | 2 | N | 320021426 | TRIAL |
| 320004166 | 320002565 | 1.76 | 61 | Neo-adjuvant (N) | 2017-12-15 | 2017-12-17 | Capecitabine (21days) + Carboplatin | N | N | 320021429 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320004167 | 320002566 | null | null | Palliative (P) | 2018-03-05 | 2018-03-07 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 320021433 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320004168 | 320005152 | 1.31 | 64 | Palliative (P) | 2016-05-28 | 2016-06-15 | Paclitaxel 7 day | N | N | 320021435 | CHOP R |
| 320004169 | 320002567 | 1.71 | 84.4 | Palliative (P) | 2015-09-24 | 2015-10-15 | Cisplatin + Etoposide (3 day) | 02 | N | 320021512 | CVD |
| 320004170 | 320002568 | 1.84 | 76.8 | Palliative (P) | 2014-10-30 | 2015-11-01 | Carboplatin + Liposomal Doxorubicin | 02 | N | 320021540 | TRIAL |
| 320004171 | 320002569 | 1.77 | 49 | Adjuvant (A) | 2018-05-16 | 2018-05-16 | Trial Unspecified | 2 | N | 320021548 | ICON TRIAL |
| 320004172 | 320002569 | 1.73 | null | Adjuvant (A) | 2015-09-18 | 2015-10-02 | Enzalutamide | N | null | 320021548 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 320004173 | 320002569 | 1.8 | 81.2 | Palliative (P) | null | 2018-02-26 | Trial Unspecified | N | N | 320021548 | CARBO + FLUOROURACIL |
| 320004174 | 320002569 | 1.48 | 68 | Palliative (P) | null | 2015-12-02 | CARBOPLATIN + FLUOROURACIL | N | null | 320021548 | CAPECITABINE + CISPLATIN |
| 320004175 | 320002569 | 1.59 | null | Palliative (P) | null | 2015-02-18 | ICON8 TRIAL | null | null | 320021548 | DE-ESCALATE TRIAL |
| 320004176 | 320002569 | null | 77.95 | Palliative (P) | null | 2017-08-10 | Cetuximab + Radiotherapy Load | N | N | 320021548 | DACARBAZINE |
| 320004177 | 320002570 | 1.7 | 0 | Palliative (P) | 2018-12-29 | 2019-01-06 | Cetuximab +Cisplatin + FU (Cycle 1) | N | N | 320021588 | PEMBROLIZUMAB |
| 320004178 | 320002571 | 1.72 | 0 | Palliative (P) | 2018-07-27 | 2018-07-27 | BCG Intravesical | Y | N | 320021591 | CETUXIMAB + RT |
| 320004179 | 320002572 | null | 78 | Curative (C) | 2015-01-06 | 2015-01-07 | null | 2 | N | 320021596 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320004180 | 320002573 | 1.7 | 95 | Neo-adjuvant (N) | 2017-07-17 | 2017-08-23 | CompARE Trial | N | N | 320021623 | BCG |
| 320004181 | 320002573 | null | 51.65 | Neo-adjuvant (N) | 2018-01-21 | 2018-01-28 | Cisplatin + Docetaxel +Fluorouracil | null | null | 320021623 | PACLITAXEL |
| 320004182 | 320002574 | null | null | Neo-adjuvant (N) | 2014-01-12 | 2014-01-12 | Cisplatin + Etoposide (3 day) | null | null | 320021663 | NOT MATCHED |
| 320004183 | 320002575 | 1.8 | 98.6 | Palliative (P) | null | 2018-01-10 | CARBOPLATIN + RT | 01 | N | 320021666 | IPILIMUMAB |
| 320004184 | 320002576 | null | 51.65 | Palliative (P) | null | 2017-04-08 | PEMBROLIZUMAB | null | null | 320021720 | THALIDOMIDE |
| 320004185 | 320002577 | 1.87 | 86.3 | Neo-adjuvant (N) | 2016-06-27 | 2016-06-27 | CISPLATIN + GEMCITABINE | N | N | 320021737 | BCG |
| 320004186 | 320002578 | 1.56 | 56.6 | Palliative (P) | 2016-03-07 | 2016-03-13 | Cisplatin + Docetaxel +Fluorouracil | N | N | 320021747 | BEVACIZUMAB |
| 320004187 | 320002579 | 1.52 | null | Adjuvant (A) | null | 2019-08-13 | BCG Intravesical | null | null | 320021762 | TRIAL |
| 320004188 | 320002580 | 0 | null | Palliative (P) | 2016-02-12 | 2016-02-19 | PEMBROLIZUMAB | 02 | N | 320021766 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 320004189 | 320002580 | null | null | Palliative (P) | 2014-02-07 | 2017-03-12 | Trial Unspecified | null | null | 320021766 | CARBOPLATIN + DOCETAXEL |
| 320004190 | 320002581 | 0 | 56 | Curative (C) | 2014-03-19 | 2014-04-01 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 2 | null | 320021777 | OXALIPLATIN + MDG |
| 320004191 | 320002581 | null | 81.5 | null | null | 2017-11-11 | CISPLATIN + GEMCITABINE | null | null | 320021777 | POUT TRIAL |
| 320004192 | 320002582 | 1.68 | 66 | Curative (C) | 2018-10-29 | 2018-10-29 | Carboplatin + Cetux + FU (Cycle 1) | 02 | null | 320021787 | CARBOPLATIN + ETOPOSIDE |
| 320004193 | 320002583 | 1.57 | 88.2 | Adjuvant (A) | 2016-02-12 | 2016-02-14 | CHOP R - 21 days | N | N | 320021788 | CARBOPLATIN + PEMETREXED |
| 320004194 | 320002584 | 1.57 | 50.3 | Palliative (P) | 2018-08-24 | 2018-09-08 | CAPECITABINE + CARBOPLATIN + Cetuximab | N | Y | 320021815 | TEMOZOLOMIDE + RT |
| 320004195 | 320002585 | 1.57 | 54.3 | Adjuvant (A) | 2018-01-23 | 2018-01-23 | Temozolomide + RT | 01 | N | 320021867 | TRABECTEDIN |
| 320004196 | 320002586 | null | null | null | 2014-05-13 | 2014-05-16 | Cisplatin + Fluorouracil + RT 5day | Y | null | 320021869 | CARBOPLATIN + LIPOSOMAL DOX |
| 320004197 | 320002586 | 1.6 | null | Not known (9) | 2015-11-30 | 2015-12-23 | Trial Unspecified | N | Y | 320021869 | TRIAL |
| 320004198 | 320002587 | null | 53 | Disease modification (D) | 2016-06-28 | 2016-07-01 | CARBOPLATIN + Cetuximab + FLUOROURACIL | null | null | 320021895 | TEMOZOLOMIDE |
| 320004199 | 320002588 | 1.87 | null | Neo-adjuvant (N) | 2017-08-13 | 2017-08-21 | CARBOPLATIN + RT | 02 | N | 320021904 | EVEROLIMUS |
| 320004200 | 320002588 | 1.65 | 67.4 | Palliative (P) | 2014-02-10 | 2014-04-06 | Carboplatin + Etoposide IV 3 day | N | N | 320021904 | CAPECITABINE + CARBOPLATIN |
| 320004201 | 320002588 | 1.77 | 61.8 | null | 2018-05-10 | 2018-05-14 | CISPLATIN + GEMCITABINE | 02 | N | 320021904 | CETUXIMAB + RT |
| 320004202 | 320002588 | 1.8 | 64.8 | Neo-adjuvant (N) | 2017-03-25 | 2017-03-31 | BCG Intravesical | 2 | N | 320021904 | ENZALUTAMIDE |
| 320004203 | 320007238 | 1.57 | 79 | Neo-adjuvant (N) | 2016-03-01 | 2016-03-14 | DOXORUBICIN | 02 | N | 320022045 | MITOMYCIN |
| 320004204 | 320007238 | 1.72 | 82.3 | Curative (C) | 2018-04-29 | 2018-05-09 | EOX | 2 | N | 320022045 | CISPLATIN + PEMETREXED |
| 320004205 | 320007238 | 1.63 | 60.05 | Palliative (P) | 2017-04-23 | 2017-05-01 | Doxorubicin + Ifosfamide | 02 | N | 320022045 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 320004206 | 320007238 | 1.61 | 80 | Neo-adjuvant (N) | 2015-01-30 | 2015-02-17 | Trial Unspecified | N | N | 320022045 | BEVACIZUMAB + CARBO + GEMCITABINE |
| 320004207 | 320002589 | 1.8 | 104.5 | Adjuvant (A) | 2016-07-21 | 2016-08-11 | BCG Intravesical | N | N | 320022132 | TRIAL |
| 320004208 | 320002590 | 1.62 | 70.5 | Palliative (P) | 2017-10-17 | 2017-10-21 | null | 2 | N | 320022167 | CISPLATIN + GEMCITABINE |
| 320004209 | 320002590 | 1.75 | null | Palliative (P) | 2016-05-04 | 2016-05-14 | Cisplatin + Etoposide (3 day) | N | N | 320022167 | NOT MATCHED |
| 320004210 | 320002590 | 1.67 | 65 | Neo-adjuvant (N) | 2015-11-25 | 2015-12-01 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 320022167 | VIDE |
| 320004211 | 320002590 | null | 70 | Adjuvant (A) | 2016-05-08 | 2016-06-05 | CHOP R - 21 days | N | Y | 320022167 | CISPLATIN + GEMCITABINE |